STANLEY T CROOKE

CIK 897667 · Exec Chairman of the Board · last filed 2021-01-28

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$36.37M

Companies

3

Total Filings

113

Lifetime Open-Market Net

-$90.12M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
IONS Exec Chairman of the Board 496,412 $73.28 $36.37M -$50.31M 51 2021-01-28
IONIS PHARMACEUTICALS INC (ISIS) Delisted Chairman and CEO 32,776 -$42.81M 60 2015-10-23
Regulus Therapeutics Inc. (RGLS) Delisted Director 7,049,500 $8.16 $57.52M $3.00M 2 2012-11-07

Recent Filings · Page 4 of 12

113 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2017-10-17 IONS Mixed -$749.9K EDGAR
2017-10-04 IONS Mixed −16,500 -$1.30M EDGAR
2017-07-24 IONS Mixed -$454.7K EDGAR
2017-07-18 IONS Mixed -$634.2K EDGAR
2017-07-03 IONS Mixed -$728.6K EDGAR
2017-04-27 IONS Mixed -$669.2K EDGAR
2017-04-21 IONS Mixed -$198.0K EDGAR
2017-04-13 IONS Mixed +500 -$710.4K EDGAR
2017-03-06 IONS Mixed -$526.6K EDGAR
2017-01-18 IONS Mixed +13,877 -$738.6K EDGAR
Showing 3140 of 113
Page 4 of 12
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.